• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性与阿片类物质使用障碍治疗:从康复女性、曾尝试药物治疗的女性以及健康和刑事司法专业人员的视角看治疗成功的因素

Women and Treatment for Opioid Use Disorder: Contributors to Treatment Success From the Perspectives of Women in Recovery, Women With Past Attempts in Drug Treatment, and Health and Criminal Justice Professionals.

作者信息

Skogseth Emma M, Brant Kristina, Harrison Eric, Apsley Hannah B, Crowley Max, Schwartz Robert P, Jones Abenaa A

机构信息

Department of Human Development and Family Studies, The Pennsylvania State University, University Park, PA, USA.

Department of Agricultural Economics, Society, and Education, The Pennsylvania State University, University Park, PA, USA.

出版信息

Subst Use. 2024 Jan 10;18:11782218231222339. doi: 10.1177/11782218231222339. eCollection 2024 Jan-Dec.

DOI:10.1177/11782218231222339
PMID:38433748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10906498/
Abstract

INTRODUCTION

The disproportionate incidence of opioid use disorder (OUD) and the alarming increases in opioid-related overdose deaths among women highlight a clear need for the expansion of effective harm reduction and treatment practices. Research supports medications for opioid use disorders (MOUD) as an effective intervention; however, with low rates of utilization of such, there is a need to identify factors that facilitate MOUD treatment uptake and retention for women. Thus, the current study examines contributors to treatment success through the triangulation of perspectives from affected women as well as health and criminal justice professionals.

METHODS

Interviews (N = 42) were conducted from May to July 2022 with women in recovery who previously used or currently use MOUD (N = 10), women who currently use opioids who terminated a MOUD program previously (N = 10), SUD treatment professionals (N = 12), and criminal justice professionals who work with women who use opioids (N = 10). Interviews for all participants centered around their backgrounds, perceived barriers and facilitators to MOUD treatment, and issues specific to women in treatment for substance use disorder. We used a thematic qualitative data analysis process to analyze transcripts.

RESULTS

Participants highlighted contributors to treatment success from 3 domains: (1) internal processes (including promoting self-efficacy and setting realistic goals), (2) access to resources (including material resources, such as food and shelter, educational resources and social support), and (3) treatment structure (such as treatment type and protocol).

CONCLUSION

Internal processes, access to resources, and treatment structure contribute to MOUD treatment success for women with OUD. Structured support where experiences are shared, and realistic goals are set, may promote feelings of acceptance and empowerment, thereby bolstering chances of treatment success. Additionally, the court system can promote evidence-based and trauma-informed substance use treatment and provide accessible educational resources related to substance use to extend these benefits to more women.

摘要

引言

阿片类药物使用障碍(OUD)的发病率在性别上存在差异,且女性中与阿片类药物相关的过量死亡人数惊人增加,这凸显了扩大有效减少伤害和治疗措施的迫切需求。研究支持将阿片类药物使用障碍药物(MOUD)作为一种有效干预措施;然而,由于此类药物的利用率较低,有必要确定促进女性接受和持续使用MOUD治疗的因素。因此,本研究通过综合受影响女性以及健康和刑事司法专业人员的观点,探讨治疗成功的影响因素。

方法

2022年5月至7月,对处于康复期的女性(N = 42)进行了访谈,这些女性曾使用或正在使用MOUD(N = 10)、曾使用阿片类药物且此前终止了MOUD项目的女性(N = 10)、物质使用障碍(SUD)治疗专业人员(N = 12)以及与使用阿片类药物的女性打交道的刑事司法专业人员(N = 10)。所有参与者的访谈都围绕她们的背景、对MOUD治疗的感知障碍和促进因素,以及物质使用障碍治疗中女性特有的问题展开。我们使用主题定性数据分析过程来分析访谈记录。

结果

参与者强调了治疗成功的三个领域的影响因素:(1)内部过程(包括提高自我效能感和设定现实目标)、(2)资源获取(包括物质资源,如食物和住所、教育资源和社会支持)以及(3)治疗结构(如治疗类型和方案)。

结论

内部过程、资源获取和治疗结构有助于患有OUD的女性在MOUD治疗中取得成功。提供结构化支持,让她们分享经历并设定现实目标,可能会增强她们的接纳感和赋权感,从而提高治疗成功的机会。此外,法院系统可以促进基于证据和创伤知情的物质使用治疗,并提供与物质使用相关的可获取教育资源,将这些益处扩展到更多女性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97c/10906498/eb67a01efa2e/10.1177_11782218231222339-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97c/10906498/eb67a01efa2e/10.1177_11782218231222339-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97c/10906498/eb67a01efa2e/10.1177_11782218231222339-fig1.jpg

相似文献

1
Women and Treatment for Opioid Use Disorder: Contributors to Treatment Success From the Perspectives of Women in Recovery, Women With Past Attempts in Drug Treatment, and Health and Criminal Justice Professionals.女性与阿片类物质使用障碍治疗:从康复女性、曾尝试药物治疗的女性以及健康和刑事司法专业人员的视角看治疗成功的因素
Subst Use. 2024 Jan 10;18:11782218231222339. doi: 10.1177/11782218231222339. eCollection 2024 Jan-Dec.
2
The impact of family systems and social networks on substance use initiation and recovery among women with substance use disorders.家庭系统和社会网络对女性物质使用障碍者物质使用起始和康复的影响。
Psychol Addict Behav. 2024 Dec;38(8):850-859. doi: 10.1037/adb0001007. Epub 2024 Apr 25.
3
Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians.在刑事司法系统中使用药物治疗阿片类药物使用障碍的障碍和促进因素:临床医生的观点。
J Subst Use Addict Treat. 2023 Jun;149:209051. doi: 10.1016/j.josat.2023.209051. Epub 2023 Apr 19.
4
Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators.纽约阿片类药物干预法庭中转介和参与物质使用障碍治疗:实施障碍和促进因素的定性研究。
Subst Abuse Treat Prev Policy. 2024 Jan 29;19(1):12. doi: 10.1186/s13011-024-00593-y.
5
A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System.《在刑事司法系统中实施治疗阿片类药物使用障碍药物的障碍和促进因素的范围综述》。
Int J Drug Policy. 2020 Jul;81:102768. doi: 10.1016/j.drugpo.2020.102768. Epub 2020 May 20.
6
"Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness.“厌倦了生病和疲惫”:探索在无家可归者中开始使用治疗阿片类药物使用障碍的药物。
J Subst Abuse Treat. 2022 Jul;138:108752. doi: 10.1016/j.jsat.2022.108752. Epub 2022 Feb 23.
7
Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study.提高法律体系内退伍军人阿片类药物使用障碍药物治疗实施率的策略:一项定性研究。
J Subst Abuse Treat. 2021 Oct;129:108353. doi: 10.1016/j.jsat.2021.108353. Epub 2021 Mar 4.
8
Criminal problem-solving and civil dependency court policies regarding medications for opioid use disorder.刑事问题解决和民事依赖法庭政策中有关阿片类药物使用障碍的药物治疗。
Subst Abus. 2022;43(1):425-432. doi: 10.1080/08897077.2021.1944958. Epub 2021 Jul 8.
9
Pregnancy- and parenting-related barriers to receiving medication for opioid use disorder: A multi-paneled qualitative study of women in treatment, women who terminated treatment, and the professionals who serve them.妊娠和育儿相关因素对接受阿片类药物使用障碍药物治疗的阻碍:一项对治疗中的女性、终止治疗的女性以及为其提供服务的专业人员进行的多层面定性研究。
Womens Health (Lond). 2024 Jan-Dec;20:17455057231224181. doi: 10.1177/17455057231224181.
10
Massachusetts Justice Community Opioid Innovation Network (MassJCOIN).马萨诸塞州司法社区阿片类药物创新网络(MassJCOIN)。
J Subst Abuse Treat. 2021 Sep;128:108275. doi: 10.1016/j.jsat.2021.108275. Epub 2021 Jan 8.

引用本文的文献

1
The role of micro-, meso-, and macro-level stigma on the uptake of medications for opioid use disorder (MOUD) among women in the criminal legal system.微观、中观和宏观层面的耻辱感对刑事法律系统中女性使用阿片类药物使用障碍药物(MOUD)的影响。
BMC Womens Health. 2025 Jul 25;25(1):370. doi: 10.1186/s12905-025-03863-4.
2
MENTAL HEALTH CARE BARRIERS FOR WOMEN INVOLVED IN THE CRIMINAL LEGAL SYSTEM WITH SUBSTANCE USE DISORDERS: A Qualitative Study.涉及刑事法律系统且患有物质使用障碍的女性的心理健康护理障碍:一项定性研究。
Crim Justice Behav. 2025 Jul;52(7):1049-1066. doi: 10.1177/00938548251326174. Epub 2025 Mar 25.
3
Outcomes following two models of treatment linkage facilitation for women with a history of OUD following jail release.

本文引用的文献

1
The Lived Experience of Medication for Opioid Use Disorder: Qualitative Metasynthesis.阿片类药物使用障碍药物治疗的体验:定性综合分析。
J Addict Nurs. 2023;34(3):E119-E134. doi: 10.1097/JAN.0000000000000475.
2
Facilitating factors and barriers for use of medications to treat opioid use disorder (MOUD) among justice-involved individuals in rural Appalachia.促进农村阿巴拉契亚地区有犯罪前科的个体使用药物治疗阿片类药物使用障碍(MOUD)的因素和障碍。
J Community Psychol. 2024 Nov;52(8):997-1014. doi: 10.1002/jcop.23029. Epub 2023 Mar 17.
3
Sorting through life: evaluating patient-important measures of success in a medication for opioid use disorder (MOUD) treatment program.
两种出狱后有药物使用障碍史女性的治疗衔接促进模式的治疗结果。
J Subst Use Addict Treat. 2025 Jul;174:209702. doi: 10.1016/j.josat.2025.209702. Epub 2025 Apr 24.
4
Adverse effects of criminal legal system involvement: a qualitative study examining the role of incarceration and reentry on substance use trajectories among women with opioid use disorders.刑事法律系统介入的不良影响:一项定性研究,考察监禁和重新融入社会对患有阿片类药物使用障碍女性的物质使用轨迹的作用。
BMC Glob Public Health. 2024 May 1;2(1):26. doi: 10.1186/s44263-024-00058-1.
5
Challenges and recommendations for overdose prevention and harm reduction in an era of fentanyl and xylazine: Perspectives of women with opioid use disorder and professionals.芬太尼和唑吡坦时代下阿片类药物使用障碍女性和专业人士对过量预防和减少伤害的挑战和建议。
Psychol Addict Behav. 2024 Dec;38(8):860-870. doi: 10.1037/adb0001021. Epub 2024 Aug 22.
6
The impact of family systems and social networks on substance use initiation and recovery among women with substance use disorders.家庭系统和社会网络对女性物质使用障碍者物质使用起始和康复的影响。
Psychol Addict Behav. 2024 Dec;38(8):850-859. doi: 10.1037/adb0001007. Epub 2024 Apr 25.
梳理生活:评估药物治疗阿片类药物使用障碍(MOUD)治疗计划中患者重要的成功措施。
Subst Abuse Treat Prev Policy. 2023 Jan 14;18(1):4. doi: 10.1186/s13011-022-00510-1.
4
Non-engagement in substance use treatment among women with an unmet need for treatment: A latent class analysis on multidimensional barriers.未满足治疗需求的女性中药物使用治疗的非参与:基于多维障碍的潜在类别分析。
Drug Alcohol Depend. 2023 Jan 1;242:109715. doi: 10.1016/j.drugalcdep.2022.109715. Epub 2022 Dec 5.
5
Providing peer navigation services to women with a history of opioid misuse pre- and post-release from jail: A program description.为有阿片类药物滥用史的女性在入狱前和出狱后提供同伴导航服务:一项项目描述。
J Clin Transl Sci. 2022 Aug 10;6(1):e106. doi: 10.1017/cts.2022.441. eCollection 2022.
6
Women-Reported Barriers and Facilitators of Continued Engagement with Medications for Opioid Use Disorder.女性报告的阿片类药物使用障碍药物治疗持续参与的障碍和促进因素。
Int J Environ Res Public Health. 2022 Jul 30;19(15):9346. doi: 10.3390/ijerph19159346.
7
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019".美国阿片类药物使用障碍的治疗差距是否缩小了?2010 年至 2019 年的年度评估。
Int J Drug Policy. 2022 Dec;110:103786. doi: 10.1016/j.drugpo.2022.103786. Epub 2022 Aug 4.
8
What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size.2010年至2019年期间,美国阿片类药物使用障碍的患病率及趋势如何?采用乘数法估算未知人口规模的患病率。
Drug Alcohol Depend Rep. 2022 Jun;3. doi: 10.1016/j.dadr.2022.100052. Epub 2022 Apr 8.
9
"You're Not Supposed to be on it Forever": Medications to Treat Opioid Use Disorder (MOUD) Related Stigma Among Drug Treatment Providers and People who Use Opioids.“你不应该永远依赖它”:治疗阿片类药物使用障碍(MOUD)的药物在药物治疗提供者和使用阿片类药物者中相关的污名化问题
Subst Abuse. 2022 Jun 27;16:11782218221103859. doi: 10.1177/11782218221103859. eCollection 2022.
10
What is success in treatment for opioid use disorder? Perspectives of physicians and patients in primary care settings.治疗阿片类药物使用障碍的成功标准是什么?初级保健环境中医生和患者的观点。
J Subst Abuse Treat. 2022 Oct;141:108804. doi: 10.1016/j.jsat.2022.108804. Epub 2022 May 20.